MiR-492 is functionally involved in Oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147

The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature

(2014) Lijuan Xiong et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma

(2014) Ruijing Lu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer

(2014) Juozas Kupcinskas et al.   Scientific Reports

A miRNA-492 binding-site polymorphism in BSG (basigin) confers risk to psoriasis in Central South Chinese population

(2011) Li-Sha Wu et al.   HUMAN GENETICS

Global Patterns of Cancer Incidence and Mortality Rates and Trends

(2010) A. Jemal et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma

(2010) Julia von Frowein et al.   HEPATOLOGY

Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma

(2008) J. Montero et al.   CANCER RESEARCH

Efficient and Stable Gene Expression into Human Osteoclasts Using an HIV-1–Based Lentiviral Vector

(2008) Kang Chu et al.   DNA AND CELL BIOLOGY

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

(2008) Lin Xia et al.   INTERNATIONAL JOURNAL OF CANCER

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

(2008) Carsten Bokemeyer et al.   JOURNAL OF CLINICAL ONCOLOGY